Survival Results from the Global Phase 3 Trial (PHOENIX) Evaluating Sodium Phenylbutyrate and Ursodoxicoltaurine in ALS

First Name*

Last Name*

Email*

By checking this box, you confirm that Amylyx may use the information you are submitting to send you corporate updates. The personal information you submit will be used only in accordance with the Amylyx Privacy Notice. You can opt out at any time through our email communications.*